期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (10)
The nature of phages was a matter of dispute, which was resolved in 1940, and it was continued to develop their activity and application in the Soviet......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (10)
Background Streptokinase, one of the most widely used thrombolytic medicines, is a favorable protein for site-specific PEGylation as it lacks any cyst......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (9)
Degenerative disc disease of the lumbosacral spine is a very common medical problem. An episode of sciatica occurs at least once in the life of 60-90%......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (1)
The green synthesis of nanomaterials is nowadays gaining great attention owing to several beneficial aspects in terms of the low toxicity of reagents ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (1)
Nucleic acids (DNA and RNA) hold great potential for the advancement of future medicine but suffer from unsatisfactory clinical success due to the cha......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (15)
Nowadays modern food preservation techniques have emerged in the last decade. Recently a combination of nanotechnology and active packaging has allowe......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (4)
Plants have substantial potential for the development of various biopharmaceuticals. Plants provide a cost-effective and direct source for the product......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (3)
Clinical analysis necessitates using rapid and dependable diagnostic methodologies and approaches. Biomarkers may be an appropriate choice to fulfill ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (6)
Introduction The dynamism in the regulatory frameworks concerning the consumption of cannabinoids has placed their effects on cognitive and psychomoto......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (7)
The conventional central dogma of molecular biology dictates that the genetic information contained within deoxyribonucleic acid (DNA) is passed onto ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (1)
Pyrexia itself is not a terminal condition. Basically, it occurs with mild to serious diseases affecting alarge population of the world. Other than a ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (9)
Background p-Coumaric acid is a phenolic compound widely distributed in fruits and vegetables that displays an array of therapeutic properties, includ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (13)
The COVID-19 pandemic has shown an adverse effect worldwide, but in India, it has been observed during the second wave that people who recovered from ......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (2)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already infected more than 272 million people, resulting in 5.3 million deaths worldw......
期刊： CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2023; 24 (11)
Bacterial engineering modifies bacteria's genomic sequence using genetic engineering tools. These engineered bacteria can produce modified proteins, p......
